Jury Backs C.R. Bard In AngioDynamics Antitrust Case
Executive Summary
A New York jury found for C.R. Bard in an antitrust case brought by competitor AngioDynamics, who said that the way Bard packaged its catheter tip location systems preloaded into central lines was anti-competitive.
You may also be interested in...
News We're Watching – 27 January
This feature compiles news briefs on a range of US regulatory and legal happenings. This week: Medtronic seeks HeartWare batteries; companies sign health equity pledge; insulin dosing app cleared; recall on field decontamination kits; and the renewal of an FDA panel.
Product Liability Missteps Top List Of Worst Legal Verdicts Of 2022
A recent webinar ranking last year’s best and worst legal verdicts said that product liability cases involving pelvic mesh and artificial lenses were the very worst.
J&J Subsidiary Pays $9.75M To Resolve Kickback Allegations
DePuy Synthes reportedly provided a Massachusetts surgeon with more than $100,000 in free implants and tools.